Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Expert Review of Gastroenterology & Hepatology|September 22, 2021
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disordersVincenzo Savarino, Luca Antonioli, Matteo Fornai, et al.
The Journal of Pharmacy and Pharmacology|December 8, 2022
Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitisRocchina Colucci, Matteo Fornai, Luca Antonioli, et al.
Frontiers in Pharmacology|July 8, 2024
Gut-directed therapy in Parkinson's diseaseLaura Benvenuti, Clelia Di Salvo, Gabriele Bellini, et al.
Pharmaceutics|January 28, 2026
The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future PerspectivesClelia Di Salvo, Giulia Valdiserra, Stefano Balestrieri, et al.
The Oncologist|November 3, 2010
Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathyMarco Tuccori, Daniele Focosi, Corrado Blandizzi, et al.
Postgraduate Medicine|August 3, 2010
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an updateMarco Tuccori, Sabrina Montagnani, Arianna Testi, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 19, 2019
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathyMatteo Fornai, Carolina Pellegrini, Laura Benvenuti, et al.
British Journal of Pharmacology|July 24, 2012
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1Rocchina Colucci, Matteo Fornai, Emiliano Duranti, et al.
Frontiers in Pharmacology|January 7, 2026
Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axisChristian Lambiase, Francesco Rettura, Giusi Desirè Sciumè, et al.
Hypertension (Dallas, Tex. : 1979)|April 22, 2009
Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoidsAgostino Virdis, Rocchina Colucci, Daniele Versari, et al.
Pageof 13